Urantide improves atherosclerosis by controlling C-reactive protein, monocyte chemotactic protein-1 and transforming growth factor-β expression in rats
Juan Zhao(Xihua University), Xiaohong Yang(Jilin University), Ya-Qin Xie(Chengde Medical University), Xiaoxia Mao(Shanghai University), Hong‐Ren Yu(University of Massachusetts Lowell), Yan Shi(Chongqing Maternal and Child Health Hospital), Lide Xie(Chengde Medical University), Shasha Liu(Fujian Agriculture and Forestry University), Ying Li(Jinan University), Liqun Ren(University of Copenhagen), QUAN-XIN YU(Chengde Medical University), Chengjun Song(China Pharmaceutical University)
Cited by 13
Related Papers
Plasma Levels of Insulin-Like Growth Factor-I and Lung Cancer Risk: a Case-Control Analysis
|JNCI Journal of the National Cancer Institute|1999|558
Host Immune Response to Influenza A Virus Infection
|Frontiers in Immunology|2018|464
Rational stepwise approach for Mycoplasma pneumoniae pneumonia in children
|Journal of Microbiology Immunology and Infection|2020|203
Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease
|Acta Paediatrica|2010|134
The Effects of Resveratrol in the Treatment of Metabolic Syndrome
|International Journal of Molecular Sciences|2019|134